Latest Insider Transactions at Applied Molecular Transport Inc. (AMTI)
This section provides a real-time view of insider transactions for Applied Molecular Transport Inc. (AMTI). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Applied Molecular Transport Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Applied Molecular Transport Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 27
2023
|
Epiq Capital Group, LLC |
SELL
Other acquisition or disposition
|
Indirect |
8,337,518
-67.54%
|
-
|
|
Dec 27
2023
|
Aaron Van Devender Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
212,659
-100.0%
|
-
|
|
Dec 27
2023
|
Shawn Cross CEO & Chair of the Board |
SELL
Sale (or disposition) back to the issuer
|
Direct |
545,499
-100.0%
|
-
|
|
Dec 27
2023
|
Brandon Hants CFO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
301,225
-100.0%
|
-
|
|
Dec 27
2023
|
Tahir Ph.D. Mahmood Director |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
3,600,000
-100.0%
|
-
|
|
Dec 27
2023
|
Tahir Ph.D. Mahmood Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
484,738
-100.0%
|
-
|
|
Nov 22
2023
|
Tahir Ph.D. Mahmood Director |
SELL
Open market or private sale
|
Direct |
286,320
-37.13%
|
$0
$0.16 P/Share
|
|
Nov 22
2023
|
Brandon Hants CFO |
SELL
Open market or private sale
|
Direct |
61,494
-16.95%
|
$0
$0.16 P/Share
|
|
Nov 22
2023
|
Shawn Cross CEO & Chair of the Board |
SELL
Open market or private sale
|
Direct |
110,802
-16.88%
|
$0
$0.16 P/Share
|
|
Nov 15
2023
|
Shawn Cross CEO & Chair of the Board |
SELL
Open market or private sale
|
Direct |
90,447
-12.11%
|
$0
$0.16 P/Share
|
|
Nov 15
2023
|
Brandon Hants CFO |
SELL
Open market or private sale
|
Direct |
50,146
-12.15%
|
$0
$0.16 P/Share
|
|
Oct 06
2023
|
Tahir Ph.D. Mahmood Director |
SELL
Open market or private sale
|
Direct |
184,442
-19.3%
|
$0
$0.16 P/Share
|
|
Oct 05
2023
|
Tahir Ph.D. Mahmood Director |
BUY
Grant, award, or other acquisition
|
Direct |
886,111
+48.12%
|
-
|
|
Sep 29
2023
|
Brandon Hants CFO |
SELL
Open market or private sale
|
Direct |
107,540
-20.55%
|
$0
$0.16 P/Share
|
|
Sep 29
2023
|
Shawn Cross CEO & Chair of the Board |
SELL
Open market or private sale
|
Direct |
193,960
-20.5%
|
$0
$0.16 P/Share
|
|
Sep 28
2023
|
Brandon Hants CFO |
BUY
Grant, award, or other acquisition
|
Direct |
491,111
+48.41%
|
-
|
|
Sep 28
2023
|
Shawn Cross CEO & Chair of the Board |
BUY
Grant, award, or other acquisition
|
Direct |
886,111
+48.36%
|
-
|
|
Sep 05
2023
|
Tahir Ph.D. Mahmood Director |
SELL
Open market or private sale
|
Direct |
2,245
-3.13%
|
$0
$0.21 P/Share
|
|
Sep 05
2023
|
Shawn Cross CEO & Chair of the Board |
SELL
Open market or private sale
|
Direct |
1,253
-0.17%
|
$0
$0.21 P/Share
|
|
Sep 05
2023
|
Brandon Hants CFO |
SELL
Open market or private sale
|
Direct |
718
-0.17%
|
$0
$0.21 P/Share
|
|
Jun 02
2023
|
Tahir Ph.D. Mahmood Director |
SELL
Open market or private sale
|
Direct |
1,992
-2.71%
|
$0
$0.24 P/Share
|
|
Jun 02
2023
|
Shawn Cross CEO & Chair of the Board |
SELL
Open market or private sale
|
Direct |
4,306
-0.19%
|
$0
$0.24 P/Share
|
|
Jun 02
2023
|
Brandon Hants CFO |
SELL
Open market or private sale
|
Direct |
2,203
-0.27%
|
$0
$0.24 P/Share
|
|
Mar 01
2023
|
Douglas A. Rich Chief Technical Officer |
SELL
Open market or private sale
|
Direct |
482
-0.97%
|
$0
$0.5 P/Share
|
|
Mar 01
2023
|
Bittoo Kanwar Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
539
-0.69%
|
$0
$0.5 P/Share
|
|
Mar 01
2023
|
Tahir Ph.D. Mahmood Director |
SELL
Open market or private sale
|
Direct |
1,802
-2.39%
|
$0
$0.5 P/Share
|
|
Mar 01
2023
|
Shawn Cross CEO & Chair of the Board |
SELL
Open market or private sale
|
Direct |
934
-1.53%
|
$0
$0.5 P/Share
|
|
Mar 01
2023
|
Brandon Hants CFO |
SELL
Open market or private sale
|
Direct |
504
-1.54%
|
$0
$0.5 P/Share
|
|
Dec 02
2022
|
Bittoo Kanwar Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
3,488
-4.25%
|
$3,488
$1.05 P/Share
|
|
Dec 02
2022
|
Tahir Ph.D. Mahmood Director |
SELL
Open market or private sale
|
Direct |
1,772
-2.3%
|
-
|
|
Dec 02
2022
|
Randall Ph.D. Mrsny Director |
SELL
Open market or private sale
|
Direct |
418
-1.94%
|
$418
$1.05 P/Share
|
|
Dec 02
2022
|
Douglas A. Rich Chief Technical Officer |
SELL
Open market or private sale
|
Direct |
4,229
-7.83%
|
$4,229
$1.05 P/Share
|
|
Dec 02
2022
|
Shawn Cross CEO & Chair of the Board |
SELL
Open market or private sale
|
Direct |
3,893
-5.99%
|
$3,893
$1.05 P/Share
|
|
Dec 02
2022
|
Brandon Hants CFO |
SELL
Open market or private sale
|
Direct |
1,959
-5.63%
|
$1,959
$1.05 P/Share
|
|
Nov 28
2022
|
Aaron Van Devender Director |
BUY
Open market or private purchase
|
Direct |
50,000
+19.04%
|
$50,000
$1.0 P/Share
|
|
Nov 25
2022
|
Aaron Van Devender Director |
BUY
Open market or private purchase
|
Direct |
100,000
+38.07%
|
$100,000
$1.0 P/Share
|
|
Sep 01
2022
|
Douglas A. Rich Chief Technical Officer |
SELL
Open market or private sale
|
Direct |
448
-0.82%
|
$448
$1.42 P/Share
|
|
Sep 01
2022
|
Randall Ph.D. Mrsny Director |
SELL
Open market or private sale
|
Direct |
404
-1.84%
|
$404
$1.42 P/Share
|
|
Sep 01
2022
|
Tahir Ph.D. Mahmood Director |
SELL
Open market or private sale
|
Direct |
1,723
-2.27%
|
$1,723
$1.42 P/Share
|
|
Sep 01
2022
|
Bittoo Kanwar Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
503
-0.61%
|
$503
$1.42 P/Share
|
|
Sep 01
2022
|
Brandon Hants CFO |
SELL
Open market or private sale
|
Direct |
462
-1.31%
|
$462
$1.42 P/Share
|
|
Sep 01
2022
|
Shawn Cross CEO & Chair of the Board |
SELL
Open market or private sale
|
Direct |
884
-0.67%
|
$884
$1.42 P/Share
|
|
Jun 02
2022
|
Shawn Cross CEO & Chair of the Board |
SELL
Open market or private sale
|
Direct |
2,166
-3.18%
|
$6,498
$3.04 P/Share
|
|
Jun 02
2022
|
Brandon Hants CFO |
SELL
Open market or private sale
|
Direct |
1,122
-3.26%
|
$3,366
$3.04 P/Share
|
|
Jun 02
2022
|
Bittoo Kanwar Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
2,196
-2.65%
|
$6,588
$3.04 P/Share
|
|
Jun 02
2022
|
Tahir Ph.D. Mahmood Director |
SELL
Open market or private sale
|
Direct |
1,693
-2.21%
|
$5,079
$3.04 P/Share
|
|
Jun 02
2022
|
Randall Ph.D. Mrsny Director |
SELL
Open market or private sale
|
Direct |
392
-1.92%
|
$1,176
$3.04 P/Share
|
|
Jun 02
2022
|
Douglas A. Rich Chief Technical Officer |
SELL
Open market or private sale
|
Direct |
2,602
-4.56%
|
$7,806
$3.04 P/Share
|
|
Jun 01
2022
|
Shawn Cross CEO & Chair of the Board |
SELL
Open market or private sale
|
Direct |
1,767
-2.53%
|
$3,534
$2.97 P/Share
|
|
Jun 01
2022
|
Brandon Hants CFO |
SELL
Open market or private sale
|
Direct |
915
-2.59%
|
$1,830
$2.97 P/Share
|